Brief: Benitec Biopharma Releases Third Quarter 2023 Financial Results And Provides Operational Update
Benitec Biopharma Inc BNTC.O :
* BENITEC BIOPHARMA RELEASES THIRD QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES OPERATIONAL UPDATE
* BENITEC BIOPHARMA INC - QTRLY LOSS PER SHARE $0.16
* BENITEC BIOPHARMA INC - AS OF MARCH 31, HAD $6.6 MILLION
IN CASH
AND CASH EQUIVALENTS
* BENITEC BIOPHARMA INC - AS OF MARCH 31, 2023, COMPANY HAD
$6.6
MILLION IN CASH AND CASH EQUIVALENTS
Source text for Eikon: ID:nGNX95MX9Q
Further company coverage: BNTC.O